Adamas Pharmaceuticals (NASDAQ:ADMS) Earnings Information
Adamas Pharmaceuticals last announced its quarterly earnings data on February 22nd, 2021. The specialty pharmaceutical company reported ($0.64) earnings per share for the quarter, missing the consensus estimate of ($0.53) by $0.11. Adamas Pharmaceuticals has generated ($3.80) earnings per share over the last year. Adamas Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.
Adamas Pharmaceuticals Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Adamas Pharmaceuticals (NASDAQ:ADMS) Earnings Estimates
2021 EPS Consensus Estimate: ($1.67)
2022 EPS Consensus Estimate: ($0.89)
Adamas Pharmaceuticals (NASDAQ ADMS) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)